-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
EBOV-GP-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/ebov-gp-in-1.gif)
| Category | Filovirus |
| Description | EBOV-GP-IN-1 (Compound 28) is a potent Ebola entry inhibitor with an IC50 of 0.05 μM against Ebola virus envelope glycoprotein (EBOV-GP). |
Product Information
| Synonyms | EBOV-GP-IN-1|CS-0564033 |
| Molecular Weight | 450.06 |
| Molecular Formula | C25H40ClN3O2 |
| Canonical SMILES | CC(C1=CC=C(C=C1)Cl)NCC(CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)O |
| Purity | >99.50% |
| Solubility | DMSO: 100 mg/mL (216.68 mM) |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 574 |
| Exact Mass | 449.2809052 |
| Target | IC50: 0.05 μM (EBOV-GP), 3.02 μM (VSV-G) |
| XLogP3-AA | 4.5 |
